Trial Profile
An Open Labelled, Randomised, Parallel Trial; Efficacy and Safety Comparison of Two Different Biphasic Insulin Aspart 30 Treatment Initiation Regimens Followed by Intensification in Subjects With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets on OADs Alone in Iran.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2013
Price :
$35
*
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2012 Actual patient number changed from 183 to 245 as reported by ClinicalTrials.gov.
- 05 Jan 2012 Actual patient number (183) added as reported by ClinicalTrials.gov.